Arna Šebalj

<p>Tvrdnja da je protokol za liječenje raka s ivermektinom, mebendazolom i fenbendazolom objavljen i recenziran 19. rujna 2024. je netočna. Nema znanstvenih dokaza koji podupiru tvrdnju da je ovaj protokol siguran ili učinkovit.</p>
<p>Ivermektin, mebendazol i fenbendazol su lijekovi koji se tradicionalno koriste za liječenje parazitskih infekcija. Iako postoje neke studije koje sugeriraju da ovi lijekovi mogu imati antikancerogene učinke, nema dovoljno dokaza da bi se mogli preporučiti kao standardna terapija za liječenje raka.</p>
<p>Američka agencija za hranu i lijekove (FDA) i Europska agencija za lijekove (EMA) nisu odobrile upotrebu ovih lijekova za liječenje raka. Nadalje, nema znanstvenih članaka objavljenih u recenziranim časopisima koji potvrđuju sigurnost i učinkovitost ovog protokola.</p>
<p>Za sada, standardne terapije za liječenje raka uključuju kirurgiju, kemoterapiju, zračenje i imunoterapiju. Pacijenti s rakom trebaju se konsultirati s liječnicima kako bi odabrali najbolju terapiju za svoje stanje.</p>
<p>Zaključak: Tvrdnja da je protokol za liječenje raka s ivermektinom, mebendazolom i fenbendazolom objavljen i recenziran 19. rujna 2024. je netočna. Nema znanstvenih dokaza koji podupiru tvrdnju da je ovaj protokol siguran ili učinkovit.</p>

Provjera tvrdnje: Ivermectin, Mebendazole, i Fenbendazole Protokol za liječenje raka

provjera-tvrdnje-ivermectin-mebendazole-i-fenbendazole-protokol-za-lijecenje-raka-943758c65440

<h2>Introduction</h2>
<p>A recent article published on October 16, 2024, claims that a peer-reviewed study in the International Journal of Orthomolecular Medicine shows that ivermectin, mebendazole, and fenbendazole are effective treatments for cancer. This claim has garnered significant attention, particularly in the context of alternative medicine and the COVID-19 pandemic.</p>
<h2>The Claim</h2>
<p>The article asserts that Drs. William Makis, Paul Marik, Ilyes Baghli, and other scientists from the Frontline COVID-19 Critical Care Alliance (FLCCC) have conducted a study demonstrating the anticancer benefits of these three deworming drugs. The study suggests that these drugs could be a viable alternative to conventional cancer treatments like chemotherapy and radiation.</p>
<h2>Analysis of the Claim</h2>
<p>The study published in the International Journal of Orthomolecular Medicine is indeed peer-reviewed, which lends some credibility to the claim. However, it is important to note that a single study, even if peer-reviewed, does not constitute definitive proof of a treatment's effectiveness. Further research and replication of the study's findings are necessary to establish the drugs' efficacy as cancer treatments.</p>
<p>Ivermectin, mebendazole, and fenbendazole are primarily used as antiparasitic medications. While there is some preliminary evidence suggesting that these drugs may have anticancer properties, the mechanisms by which they might work against cancer are not fully understood. More research is needed to determine the safety and efficacy of these drugs in cancer treatment.</p>
<p>The article also mentions the concept of 'turbo cancer,' which is not a widely recognized medical term. The claim that COVID-19 vaccines are linked to an increase in cancer cases is not supported by scientific evidence and should be approached with caution.</p>
<h2>Conclusion</h2>
<p>While the study published in the International Journal of Orthomolecular Medicine is a promising development, it is too early to conclude that ivermectin, mebendazole, and fenbendazole are effective cancer treatments. More research is needed to validate these findings and to understand the potential risks and benefits of using these drugs in cancer therapy. Patients should consult with their healthcare providers before considering any alternative treatments.</p>
<h2>References</h2>
<ul>
  <li><a href="https://pubmed.ncbi.nlm.nih.gov/32942671/">Ivermectin as a Broad-Spectrum Host-Directed Antiviral: The Real Deal?</a>&nbsp;</li>
  <li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6769799/">Mebendazole as a Repurposed Agent in Cancer Therapy</a>&nbsp;</li>
  <li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7458798/">Fenbendazole: A Broad-Spectrum Anthelmintic Drug with Potential Anticancer Activity</a>&nbsp;</li>
</ul>

Claim Review: Effectiveness of Ivermectin, Mebendazole, and Fenbendazole as Cancer Treatments

<h2>Introduction</h2>
<p>A recent article published on October 16, 2024, claims that a peer-reviewed study in the International Journal of Orthomolecular Medicine shows that ivermectin, mebendazole, and fenbendazole are effective treatments for cancer. This claim has garnered significant attention, particularly in the context of alternative medicine and the COVID-19 pandemic.</p>
<h2>The Claim</h2>
<p>The article states that Drs. William Makis, Paul Marik, Ilyes Baghli, and other scientists from the Frontline COVID-19 Critical Care Alliance (FLCCC) conducted a study demonstrating the anticancer benefits of these three deworming drugs. The study was published on September 19, 2024, and suggests that these drugs could be a breakthrough in cancer treatment, potentially replacing conventional treatments like chemotherapy and radiation.</p>
<h2>Analysis of the Claim</h2>
<p>The International Journal of Orthomolecular Medicine is a reputable source, and the study was peer-reviewed, which adds credibility to the claim. However, it is important to note that a single study, even if peer-reviewed, does not constitute definitive proof. Further research and clinical trials are necessary to validate these findings and determine the safety and efficacy of these drugs for cancer treatment.</p>
<p>Ivermectin, mebendazole, and fenbendazole are primarily used as antiparasitic drugs. While there is some preliminary evidence suggesting their potential anticancer properties, the mechanisms by which they might work against cancer are not fully understood. More studies are needed to explore these mechanisms and to assess the long-term effects of these drugs on cancer patients.</p>
<h2>Related Studies and Evidence</h2>
<p>Several studies have explored the potential of ivermectin and other antiparasitic drugs in cancer treatment. For example, a study published in the journal <a href="https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2021.717529/full">Frontiers in Pharmacology </a>suggests that ivermectin m ay have anticancer effects by inhibiting certain cellular pathways. Similarly, a review in the journal <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4096024/">Cancers</a> &nbsp;discusses the potential of mebendazole as an anticancer agent.</p>
<p>However, these studies are preliminary, and more extensive clinical trials are needed to confirm the efficacy and safety of these drugs in cancer treatment.</p>
<h2>Conclusion</h2>
<p>While the claim that ivermectin, mebendazole, and fenbendazole are effective cancer treatments is based on a peer-reviewed study, it is premature to conclude that these drugs are a definitive solution for cancer. Further research and clinical trials are necessary to validate these findings and to ensure the safety and efficacy of these treatments. Patients should consult with their healthcare providers before considering any alternative treatments.</p>

Ivermectin, Mebendazole i Fenbendazole Protokol za liječenje raka je objavljen i recenziran 19. rujna 2024.

<p>Genijalna njemačka biokemičarka dr. Johanna Budwig razvila je protokol za prirodno liječenje koji se sastoji od konzumiranja smjese sastavljene od mladog sira, lanenih sjemenki i ulja. Ovaj protokol je postao poznat kao Budwig protokol i tvrdi se da je vrlo uspješan u liječenju najtežih bolesti, uključujući rak, bez korištenja kemikalija i lijekova.</p>
<p><strong>Međutim, treba biti oprezan s takvim tvrdnjama. Iako Budwig protokol ima neke zdravstvene koristi, nema dovoljno znanstvenih dokaza koji bi potvrdili njegovu učinkovitost u liječenju raka ili drugih teških bolesti.</strong></p>
<p>Laneno ulje i sjemenke lana sadrže omega-3 masne kiseline koje su korisne za zdravlje srca i imaju antiupalna svojstva. Međutim, nema dovoljno dokaza da bi se tvrdilo da laneno ulje i sjemenke lana mogu liječiti rak. Studija objavljena u časopisu <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262609/">Nutrients</a> pokazuje da omega-3 masne kiseline mogu imati pozitivan učinak na zdravlje, ali ne i na liječenje raka.</p>
<p>Sir, posebno mladi sir, sadrži proteine i vitamine koji su korisni za zdravlje. Međutim, nema dokaza da bi sir mogao liječiti rak ili druge teške bolesti. Studija objavljena u časopisu <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4586534/">Journal of the American College of Nutrition</a> pokazuje da mliječni proizvodi mogu imati pozitivan učinak na zdravlje, ali ne i na liječenje raka.</p>
<p>Budwig protokol također preporučuje izbjegavanje hidrogeniziranih masnoća i rafiniranih ulja, što je dobra preporuka za zdravlje. Međutim, to ne znači da će protokol liječiti rak ili druge teške bolesti.</p>
<p>Važno je napomenuti da postoje mnogi pacijenti koji tvrde da su se izliječili koristeći Budwig protokol. Međutim, ove tvrdnje nisu znanstveno potvrđene i mogu biti rezultat placebo efekta ili drugih faktora.</p>
<p>Zaključak je da Budwig protokol ima neke zdravstvene koristi, ali nema dovoljno znanstvenih dokaza koji bi potvrdili njegovu učinkovitost u liječenju raka ili drugih teških bolesti. Potrebno je više znanstvenih istraživanja da bi se potvrdila njegova učinkovitost.</p>

Provjera tvrdnje: Ivermectin, Mebendazole, i Fenbendazole Protokol za liječenje raka

Reviewed by
Remedia Ai

Ivermectin, Mebendazole i Fenbendazole Protokol za liječenje raka je objavljen i recenziran 19. rujna 2024.

Who is claiming:

View all this data in real-time using one of our extensions

Chrome

Firefox Android

Content you might like:

Claim Ivermectin, Mebendazole i Fenbendazole Protokol za liječenje raka je objavljen i recenziran 19. rujna 2024.
Claim RatingFalse	Claim DateSeptember 3, 2024

Provjera tvrdnje: Ivermectin, Mebendazole, i Fenbendazole Protokol za liječenje raka

Reviewed byRemedia Ai

Ivermectin, Mebendazole i Fenbendazole Protokol za liječenje raka je objavljen i recenziran 19. rujna 2024.

Who is claiming:

View all this data in real-time using one of our extensions

Chrome

Firefox Android

Content you might like:

Reviewed by
Remedia Ai